Advertisement
Advertisement

LUCD

LUCD logo

Lucid Diagnostics Inc. Common Stock

1.23
USD
Sponsored
+0.04
+2.94%
Jan 08, 15:27 UTC -5
Closed
exchange

After-Market

1.23

0.00
0.00%

LUCD Earnings Reports

Positive Surprise Ratio

LUCD beat 7 of 17 last estimates.

41%

Next Report

Date of Next Report
Mar 23, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.49M
/
-$0.10
Implied change from Q3 25 (Revenue/ EPS)
+22.68%
/
--
Implied change from Q4 24 (Revenue/ EPS)
+24.11%
/
-44.44%

Lucid Diagnostics Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, LUCD reported earnings of -0.10 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 11.03% surprise. Revenue reached 1.21 million, compared to an expected 1.38 million, with a -12.52% difference. The market reacted with a +6.73% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 1.49 million USD, implying an increase of 0.00% EPS, and increase of 22.68% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
For Q3 2025, Lucid Diagnostics Inc. Common Stock reported EPS of -$0.10, beating estimates by 11.03%, and revenue of $1.21M, -12.52% below expectations.
The stock price moved up 6.73%, changed from $1.04 before the earnings release to $1.11 the day after.
The next earning report is scheduled for Mar 23, 2026.
Based on 8 analysts, Lucid Diagnostics Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $1.49M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement